Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer precursor lesions in the BRCA population at the time of prophylactic salpingo-oophorectomy: Accuracy of assessment and potential surrogate marker for prevention.

Gynecologic oncology - 1 Aug 2015

Lheureux Stephanie, Shaw Patricia A, Karakasis Katherine, Oza Amit M

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cystadenocarcinoma, Serous
Share to Fallopian Tubes
Share to Genes, BRCA1
Share to Genes, BRCA2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germ-Line Mutation

Share to Ovariectomy

Share to Precancerous Conditions

Source

Identifiers

PMID: 26072440
DOI: 10.1016/j.ygyno.2015.06.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer precursor lesions in the BRCA population at the time of prophylactic salpingo-oophorectomy: Accuracy of assessment and potential surrogate marker for prevention.PMID 26072440Read ↗

BRCA-associated cancer risk: molecular biology and clinical practice.Semantic proximity Read ↗

BRCA screening.Semantic proximity Read ↗

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.Semantic proximity Read ↗

Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.Semantic proximity Read ↗

Genetic risk assessment for breast and ovarian cancer.Semantic proximity Read ↗

The role of testing for BRCA1 and BRCA2 mutations in cancer prevention.Semantic proximity Read ↗

Genetic/familial high-risk assessment: breast and ovarian.Semantic proximity Read ↗

Genetic/familial high-risk assessment: breast and ovarian.Semantic proximity Read ↗

Cancer risks among BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Pros and cons of screening for BRCA mutations.Semantic proximity Read ↗

Breast cancer in young women: do BRCA1 or BRCA2 mutations matter?Semantic proximity Read ↗

Management of the BRCA mutation carrier or high-risk patient.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.